Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes
EndocrinologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Diabetes care
- Publicado em
- 1 jan 2024
- Citações
- 22
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes
Jordan S Sherwood, Luz E Castellanos, Mollie Y O'Connor, Courtney A Balliro, Mallory A Hillard, Sarah Grace Gaston, Rachel Bartholomew, Evelyn Greaux, Amy Sabean, Hui Zheng et al.
Descritores MeSH
- Diabetes Mellitus, Type 1
- Cystic Fibrosis
- Hypoglycemia
- Humans
- Hypoglycemic Agents
- Insulin
- Insulin Infusion Systems
- Pancreas
- Blood Glucose Self-Monitoring
- Adult
Veja também
Estudos relacionados
- Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial
- A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72
- Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial
- Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial